Marc Appel

Marc Spencer Appel is a seasoned healthcare investor and lawyer with a keen interest in structuring deals to support innovation in biotech, med tech, healthcare services, and pharma.

His educational background includes a BA in History and Classical Civilizations from Yale University, a JD from Harvard Law School, and an MBA from Harvard Business School, showcasing his dedication to academic excellence.

With a wealth of experience in the healthcare industry, Marc has held prominent roles such as Chief Executive Officer at Orange Grove Bio and previously at IpiNovyx Bio and Asalyxa Bio, demonstrating his leadership and strategic acumen.

He has also contributed significantly to the field through positions like Entrepreneur In Residence at Yale Office of Cooperative Research, Senior Research Analyst at Marathon Asset Management, Research Analyst at Highbridge Capital Management, and more, highlighting his diverse expertise.

Marc's professional journey has seen him engage in roles ranging from investment management at Eaton Vance to legal advisory at Kirkland & Ellis LLP and consulting at McKinsey & Company, showcasing his versatility and holistic approach to business.

Additionally, his tenure as Blanksteen Curatorial Fellow at The Jewish Museum underscores his involvement in various spheres beyond healthcare, reflecting a well-rounded professional background.